Edgewise Therapeutics Inc

NASDAQ:EWTX  
20.23
-1.42 (-6.56%)
Earnings Announcements

Edgewise Therapeutics Posts Q3 Loss Per Share $0.26

Published: 11/10/2021 15:20 GMT
Edgewise Therapeutics Inc (EWTX) - Edgewise Therapeutics Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.26.
Q3 Earnings per Share View $-0.22 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.